Infinity Pharmaceuticals, Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Infinity is a public biotechnology company advancing eganelisib, a first-in-class, oral, macrophage reprogramming therapeutic candidate addressing a fundamental biologic mechanism of immune suppression in cancer.
Ticker:
INFI
Exchange:
Nasdaq
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
eganelisib
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chair & Chief Executive Officer
Infinity Pharmaceuticals, Inc.